|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
4R00CA158065-03
|
$241,532
|
$241,532
|
RINK, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$412,354
|
$247,413
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-12
|
$5,000
|
$500
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$77,422
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
2T32CA009111-36A1
|
$358,818
|
$35,882
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$25,483
|
$25,483
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S1
|
$75,000
|
$5,250
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S2
|
$4,154
|
$291
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S3
|
$12,487
|
$874
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S4
|
$126,993
|
$8,890
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$424,988
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$3,410
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$103,950
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
1K01CA184388-01
|
$110,616
|
$110,616
|
OGEMBO, JAVIER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S1
|
$74,531
|
$745
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S2
|
$49,999
|
$500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S3
|
$310,728
|
$3,107
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-26
|
$5,914,688
|
$59,147
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
1U10CA180834-01
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
1U54CA190153-01
|
$700,186
|
$427,113
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
|
1R01CA181125-01A1
|
$316,438
|
$316,438
|
PEARCE, ERIKA
|
WASHINGTON UNIVERSITY
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$412,923
|
$412,923
|
Helman, Lee
|
CCR (NCI)
|
|
Training In Tumor Virology
|
5T32CA115299-09
|
$337,821
|
$67,564
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$531,130
|
$53,113
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Three-dimensional Model of Human Ewing Sarcoma
|
1R01CA180279-01A1
|
$336,611
|
$336,611
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$724,547
|
$181,137
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-15
|
$1,847,930
|
$332,627
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING
|
5R01CA043059-26
|
$337,116
|
$168,558
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
The Role of miRNA-mediated RNAI in the Biology of Cancer
|
ZIA BC 010612
|
$131,649
|
$26,330
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Role of JAB1 in osteosarcoma pathogenesis
|
5R03CA175874-02
|
$76,873
|
$76,873
|
ZHOU, GUANG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S3
|
$21,615
|
$432
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S1
|
$75,000
|
$1,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S2
|
$50,000
|
$1,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S3
|
$77,097
|
$1,542
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$93,723
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$219,416
|
$10,971
|
Caplen, Natasha
|
CCR (NCI)
|
|
The ARF Tumor Suppressor
|
5R01CA139319-05
|
$361,188
|
$90,297
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$498,512
|
$49,851
|
Schrump, David
|
CCR (NCI)
|
|
TGIB Surgical Consultative Services
|
ZID BC 011541
|
$1,129,960
|
$112,996
|
Schrump, David
|
CCR (NCI)
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-04
|
$340,155
|
$255,116
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
1R01CA183811-01A1
|
$427,850
|
$427,850
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell Death
|
4R00CA166517-03
|
$241,530
|
$60,383
|
DIXON, SCOTT
|
STANFORD UNIVERSITY
|
|
Targeting the chondrosarcoma extracellular matrix for drug delivery
|
1R41CA183208-01
|
$222,881
|
$222,881
|
NEIGHBORS, JEFFREY
|
TERPENOID THERAPEUTICS, INC.
|
|
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
|
ZIA BC 010999
|
$787,265
|
$629,812
|
Khan, Javed
|
CCR (NCI)
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-04
|
$296,581
|
$148,291
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-07
|
$292,042
|
$292,042
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study the roles of p53 and p53 mutants in mesenchymal stem cells
|
ZIA BC 011504
|
$378,114
|
$378,114
|
Huang, Jing
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$567,530
|
$170,259
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$198,458
|
$9,923
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
Total relevant funding to Sarcoma for this search: $71,995,071
|